INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2022

Celery seed extract was safe and improved blood pressure, fasting blood sugar, lipid profiles, and liver/kidney markers in hypertensive patients.

In a triple-blind, placebo-controlled crossover trial, 51 hypertensive patients received either celery seed capsules (1.34 g extract daily) or placebo for 4 weeks alongside usual medications. Celery seed extract was safe, reduced blood pressure, and decreased FBS from 108.53 to 97.96 mg/dL (p < 0.01). Significant reductions were seen in BUN (3.43 mg/dL), SCr (0.075 mg/dL), SGPT (4.08 U/L), SGOT (3.03 U/L), TC (16.37 mg/dL), TG (16.22 mg/dL), and LDL (11.84 mg/dL), along with an increase in HDL of 2.52 mg/dL (all p < 0.05 or p < 0.001). No significant changes were found in blood cells or serum electrolytes; the study was limited by a small sample size.

Study type
Randomized, triple-blind, placebo-controlled, cross-over clinical trial
Who was studied
51 hypertensive patients
What was measured
Safety, blood pressure, fasting blood sugar, lipid profile, liver and kidney function markers

THE PAPER

Safety evaluation and biochemical efficacy of celery seed extract (Apium Graveolens) capsules in hypertensive patients: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial.

Shayani Rad M, Moohebati M, MohammadEbrahimi S, Motamedshariaty VS, Mohajeri SA. Inflammopharmacology, 2022.

PubMed 35536382 ↗DOI 10.1007/s10787-022-00986-0 ↗

Heart & arteriesDiabetes & blood sugarBlood pressureKidney health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.